CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · IEX Real-Time Price · USD
5.20
-0.04 (-0.76%)
Apr 19, 2024, 1:55 PM EDT - Market closed
CollPlant Biotechnologies Market Cap
CollPlant Biotechnologies has a market cap or net worth of $59.56 million as of April 19, 2024. Its market cap has decreased by -29.09% in one year.
Market Cap
59.56M
Enterprise Value
36.05M
1-Year Change
-29.09%
Ranking
Category
Stock Price
$5.20
Market Cap Chart
Since January 31, 2018, CollPlant Biotechnologies's market cap has increased from $30.60M to $59.56M, an increase of 94.65%. That is a compound annual growth rate of 11.31%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 18, 2024 | 59.80M | -0.33% |
Apr 17, 2024 | 60.00M | 1.52% |
Apr 16, 2024 | 59.10M | -0.34% |
Apr 15, 2024 | 59.30M | -1.33% |
Apr 12, 2024 | 60.10M | 0.50% |
Apr 11, 2024 | 59.80M | -0.33% |
Apr 10, 2024 | 60.00M | 0.33% |
Apr 9, 2024 | 59.80M | 2.22% |
Apr 8, 2024 | 58.50M | 0.17% |
Apr 5, 2024 | 58.40M | -2.99% |
Apr 4, 2024 | 60.20M | -3.68% |
Apr 3, 2024 | 62.50M | 3.82% |
Apr 2, 2024 | 60.20M | - |
Apr 1, 2024 | 60.20M | -1.79% |
Mar 28, 2024 | 61.30M | 2.34% |
Mar 27, 2024 | 59.90M | -0.17% |
Mar 26, 2024 | 60.00M | -0.17% |
Mar 25, 2024 | 60.10M | 2.91% |
Mar 22, 2024 | 58.40M | 1.57% |
Mar 21, 2024 | 57.50M | -2.71% |
Mar 20, 2024 | 59.10M | -1.34% |
Mar 19, 2024 | 59.90M | 3.63% |
Mar 18, 2024 | 57.80M | 0.70% |
Mar 15, 2024 | 57.40M | -5.75% |
Mar 14, 2024 | 60.90M | 5.00% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
HCW Biologics | 59.38M |
vTv Therapeutics | 59.00M |
Vaxxinity | 58.84M |
Cryo-Cell International | 58.76M |
Kezar Life Sciences | 58.61M |
Aligos Therapeutics | 57.66M |
Tiziana Life Sciences | 57.44M |
Reneo Pharmaceuticals | 57.39M |